The vaping and e-cigarette sector in the US has faced challenging regulatory times due to the e-cigarette or vaping use associated lung injury (EVALI) crisis and widespread vaping by teens. However, CBD vaping products have managed to maintain a relatively stable presence in the CBD market.
The US Food and Drug Administration (FDA) has not taken any direct position on the legality of hemp-derived CBD vaping products like it has with other product categories such as food and dietary supplements.
This report covers whether each state allows the sale of hemp-derived CBD vaping products.
Anthony focuses on regulatory developments and legal analysis in the US. Anthony has a BA in political science from North Carolina State University and a JD from Charleston School of Law (South Carolina), where he was a senior editor on the law review. He practised law for several years in the United States as a litigator.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
"*" indicates required fields
Start your FREE trial
Get 7 days of access to industry updates through our news analysis and regulatory alerts
LATEST ALERTS
